Evidence map›Paper›PMID 36721988›Full record

ArticleGlycobiology2023

O-fucosylation of thrombospondin type I repeats is dispensable for trafficking thrombospondin 1 to platelet secretory granules.

Steven J Berardinelli, Andrew R Sillato, Richard C Grady, Sanjiv Neupane, Atsuko Ito, Robert S Haltiwanger, Bernadette C Holdener

Open access · greenAbstract read
In one paragraph

Article in Glycobiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Steven J BerardinelliComplex Carbohydrate Research Center, Department of Biochemistry and Molecular Biology, University of Georgia, Athens, GA 30602, USA.
Andrew R SillatoDepartment of Biochemistry and Cell Biology, Stony Brook University, Stony Brook, NY 11794, USA.
Richard C GradyDepartment of Biochemistry and Cell Biology, Stony Brook University, Stony Brook, NY 11794, USA.
Sanjiv NeupaneDepartment of Biochemistry and Cell Biology, Stony Brook University, Stony Brook, NY 11794, USA.
Atsuko ItoComplex Carbohydrate Research Center, Department of Biochemistry and Molecular Biology, University of Georgia, Athens, GA 30602, USA.
Robert S HaltiwangerComplex Carbohydrate Research Center, Department of Biochemistry and Molecular Biology, University of Georgia, Athens, GA 30602, USA.ORCID 0000-0001-7439-9577
Bernadette C HoldenerDepartment of Biochemistry and Cell Biology, Stony Brook University, Stony Brook, NY 11794, USA.ORCID 0000-0003-4713-9264
Stony Brook University · USUniversity of Georgia · US

Funding

Role of Beta3-Glucosyltransferase in a non-canonical quality control pathwayR01HD096030 · NICHD · UNIVERSITY OF GEORGIA · PI HALTIWANGER, ROBERT S., HOLDENER, BERNADETTE C · 2018 to 2022
$2.9M
Characterization of the role of POFUT2-mediated O-fucosylation in folding Thrombospondin Type 1 Repeats and Development R01HD090156 · NICHD · UNIVERSITY OF GEORGIA · PI HALTIWANGER, ROBERT S., HOLDENER, BERNADETTE C · 2017 to 2021
$2.4M
NICHD NIH HHS R01 HD090156NICHD NIH HHS R01 HD096030
6 · The paper itself

Abstract

Thrombospondin 1 (THBS1) is a secreted extracellular matrix glycoprotein that regulates a variety of cellular and physiological processes. THBS1's diverse functions are attributed to interactions between the modular domains of THBS1 with an array of proteins found in the extracellular matrix. THBS1's three Thrombospondin type 1 repeats (TSRs) are modified with O-linked glucose-fucose disaccharide and C-mannose. It is unknown whether these modifications impact trafficking and/or function of THBS1 in vivo. The O-fucose is added by Protein O-fucosyltransferase 2 (POFUT2) and is sequentially extended to the disaccharide by β3glucosyltransferase (B3GLCT). The C-mannose is added by one or more of four C-mannosyltransferases. O-fucosylation by POFUT2/B3GLCT in the endoplasmic reticulum has been proposed to play a role in quality control by locking TSR domains into their three-dimensional fold, allowing for proper secretion of many O-fucosylated substrates. Prior studies showed the siRNA knockdown of POFUT2 in HEK293T cells blocked secretion of TSRs 1-3 from THBS1. Here we demonstrated that secretion of THBS1 TSRs 1-3 was not reduced by CRISPR-Cas9-mediated knockout of POFUT2 in HEK293T cells and demonstrated that knockout of Pofut2 or B3glct in mice did not reduce the trafficking of endogenous THBS1 to secretory granules of platelets, a major source of THBS1. Additionally, we demonstrated that all three TSRs from platelet THBS1 were highly C-mannosylated, which has been shown to stabilize TSRs in vitro. Combined, these results suggested that POFUT2 substrates with TSRs that are also modified by C-mannose may be less susceptible to trafficking defects resulting from the loss of the glucose-fucose disaccharide.

Indexed as

FucosyltransferasesThrombospondin 1AnimalsFucoseGlucoseHEK293 CellsHumansMannoseMiceSecretory VesiclesThrombospondinsFucoseFucosyltransferasesGlucoseMannoseThbs1 protein, mouseThrombospondin 1thrombospondin-1, humanThrombospondinsC-mannosylationO-fucosylationPOFUT2protein traffickingthrombospondin 1

Identifiers

PMID36721988
PMCPMC10191222
OpenAlexW4318755610

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.